David Armstrong is a reporter at ProPublica, specializing in health care investigations. He joined ProPublica in March, 2018. Before that, he was a senior enterprise reporter for STAT, where he wrote about abuses in the addiction treatment industry, the rise of fentanyl and the recruiting of college football players with histories of concussions. Armstrong previously worked in the investigative unit at Bloomberg News, where he reported on the overuse of cardiac stents, problematic back surgeries and excesses in the pain industry.
Armstrong was also a reporter for nine years at the Wall Street Journal, where he reported on the influence of pharmaceutical and medical device companies on the practice of medicine – and the resulting harm to patients. He was part of the Journal staff awarded the 2002 Pulitzer Prize for breaking news reporting for coverage of the attacks of Sept. 11. Armstrong was a reporter for the Boston Globe from 1993 to 2000, where his investigation of safety flaws in elevators and escalators won a George Polk Award and the Investigative Reporters and Editors award.
Doctors working for health insurers can rule on 10,000 or more requests for care a year. At least a dozen were hired by major insurance companies after being disciplined by state medical boards or making multiple or outsized malpractice payments.
The probes follow an investigation by ProPublica and The Capitol Forum that Cigna allows its doctors to reject hundreds of thousands of claims a month.
Internal documents and former company executives reveal how Cigna doctors reject patients’ claims without opening their files. “We literally click and submit,” one former company doctor said.
After a college student finally found a treatment that worked, the insurance giant decided it wouldn’t pay for the costly drugs. His fight to get coverage exposed the insurer’s hidden procedures for rejecting claims.
Insurers deny tens of millions of claims every year. ProPublica is investigating why claims are denied, what the consequences are for patients and how the appeal process really works.
New documents show that St. Jude Children’s Research Hospital’s reserves grew to $7.6 billion, as other children's cancer nonprofits struggled to raise cash.
The high-profile children’s hospital uses donor money to engage in long and costly legal battles over wills. Here’s how St. Jude has created one of the most lucrative charitable bequest programs in the country.
St. Jude Children’s Research Hospital promises not to bill families. But the cost of having a child at the hospital for cancer care leaves some families so strapped for money that parents share tips on spending nights in the parking lot.
A settlement is about to shield members of the Sackler family from civil litigation regarding their alleged roles in the opioid crisis. So it’s a good time to release the full video of Richard Sackler’s 2015 deposition.
Lax states are attracting shoppers and students from stricter neighbors — and sending back COVID-19 cases. The imbalance underscores the lack of a national policy.
Local elected officials and the NAACP are calling for tougher supervision of private police forces, including one run by the Cleveland Clinic, after ProPublica found that these officers disproportionately arrest Black people.
Armed private police patrolling Cleveland’s medical zone and the city streets around it disproportionately charge and cite Black people, even though most hospital employees, patients and visitors are white.
State-run veterans homes, which have suffered enormously in the pandemic, fall between the regulatory cracks. The VA disclaims responsibility for them, and its inspections have overlooked issues later identified by other investigators.
When Laura Whalen went to a hospital with COVID-19, she brought her kids. Her husband was already in an ICU, and she couldn’t risk them exposing their grandma. But the state told her to find someone to take them or it would.
Cardinal Health withdrew the gowns just before the pandemic because a Chinese supplier failed to sterilize them properly. The recall has created what a hospital association official called a “ripple effect.”
Pharmacists told ProPublica that they are seeing unusual and fraudulent prescribing activity as doctors stockpile unproven coronavirus drugs endorsed by President Donald Trump.
The CDC and hospitals have put medical providers and patients at risk as they fail to address national supply shortages. One emergency room doctor who did not have proper equipment and learned he had COVID-19 said, “I’m sure I exposed everyone I saw.”
Thank you for your interest in republishing this story. You are are free to republish it so long as you do the following:
You have to credit ProPublica and any co-reporting partners. In the byline, we prefer “Author Name, Publication(s).” At the top of the text of your story, include a line that reads: “This story was originally published by ProPublica.” You must link the word “ProPublica” to the original URL of the story.
If you’re republishing online, you must link to the URL of this story on propublica.org, include all of the links from our story, including our newsletter sign up language and link, and use our PixelPing tag.
If you use canonical metadata, please use the ProPublica URL. For more information about canonical metadata, refer to this Google SEO link.
You can’t edit our material, except to reflect relative changes in time, location and editorial style. (For example, “yesterday” can be changed to “last week,” and “Portland, Ore.” to “Portland” or “here.”)
You cannot republish our photographs or illustrations without specific permission. Please contact [email protected].
It’s okay to put our stories on pages with ads, but not ads specifically sold against our stories. You can’t state or imply that donations to your organization support ProPublica’s work.
You can’t sell our material separately or syndicate it. This includes publishing or syndicating our work on platforms or apps such as Apple News, Google News, etc.
You can’t republish our material wholesale, or automatically; you need to select stories to be republished individually. (To inquire about syndication or licensing opportunities, contact [email protected].)
You can’t use our work to populate a website designed to improve rankings on search engines or solely to gain revenue from network-based advertisements.
We do not generally permit translation of our stories into another language.
Any website our stories appear on must include a prominent and effective way to contact you.
If you share republished stories on social media, we’d appreciate being tagged in your posts. We have official accounts for ProPublica on Twitter, Facebook and Instagram.
Copy and paste the following into your page to republish: